Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.82 |
| ▸ | CD38 | P28907 | 2/20 | 0.73 |
| ▸ | DPP4 | P27487 | 1/20 | 0.73 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | TYR | P14679 | 1/20 | 0.49 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.47 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | TNF | P01375 | 1/20 | 0.46 |
| ▸ | IL2 | P60568 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29530365 | 1.00 | F2 (0.82) | F2CD38DPP4EPHX2KDM4E | |
| SCHEMBL29714132 | 0.94 | CD38 (0.82) | F2CD38DPP4EPHX2KDM4E | |
| SCHEMBL29816458 | 0.94 | CD38 (0.82) | F2CD38DPP4EPHX2KDM4E | |
| SCHEMBL29389947 | 0.94 | CD38 (0.82) | F2CD38DPP4EPHX2KDM4E | |
| SCHEMBL8975217 | 0.94 | CD38 (0.82) | F2CD38DPP4EPHX2KDM4E | |
| SCHEMBL4740208 | 0.94 | F2 (0.89) | F2CD38DPP4EPHX2KDM4E | |
| Hydrochloric Acid SCHEMBL31389336 | 0.94 | CD38 (0.81) | F2CD38DPP4EPHX2KDM4E | |
| Hydrochloric Acid SCHEMBL31420442 | 0.94 | CD38 (0.81) | F2CD38DPP4EPHX2KDM4E | |
| SCHEMBL31269727 | 0.94 | CD38 (0.81) | F2CD38DPP4EPHX2KDM4E | |
| Cyanin SCHEMBL6138846 | 0.91 | F2 (1.00) | F2CD38DPP4EPHX2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230355769-A1 | COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2023-11-09 | — | — | US | claimed |
| US-20230338331-A1 | COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2023-10-26 | — | — | US | claimed |
| US-11523998-B2 | Anti-inflammatory formulations and uses thereof including a combination of palmitoylethanolamide and plant-based polyphenols | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2022-12-13 | — | — | US | claimed |
| CN-105833243-A | Medicine composition for pre-operative regulation of pelvic abscess and preparation method thereof | 张娟 | 2016-08-10 | — | — | CN | claimed |
| CN-102078443-B | Medicine composition, application and preparation thereof | TIANJIN INST PHARM RESEARCH | 2013-04-17 | — | — | CN | claimed |
| CN-102827752-A | Paeonia suffruticosa vinegar and preparation method thereof | WANG WANZHEN | 2012-12-19 | — | — | CN | claimed |
| CN-102078443-A | Medicine composition, application and preparation thereof | TIANJIN INST PHARM RESEARCH | 2011-06-01 | — | — | CN | claimed |
| US-7887868-B2 | low-salt soy sauce having an antihypertensive effect; contains 3.55% or less by weight of sodium, 0.5% to 3.6% by weight of potassium, 0.05 to 20% by weight of at least one polyphenol | KAO CORPORATION (JP) | 2011-02-15 | — | — | US | claimed |
| CN-101810686-A | Compatible composition for treating rheumatoid arthritis and preparation method thereof | NINGBO LIWAH PLANT | 2010-08-25 | — | — | CN | claimed |
| US-7727524-B2 | Low sodium liquid seasoning with anti-hypertensive activity | KAO CORPORATION (JP) | 2010-06-01 | — | — | US | claimed |
| EP-1507461-A1 | DIETARY SUPPLEMENTS FROM WINE VINASSES AND RELEVANT PRODUCTION PROCESS | Advance Holdings Limited (ML) | 2005-02-23 | — | — | EP | claimed |
| US-20040166179-A1 | Dietary supplements from wine vinasses and relevant production process | ADVANCE HOLDINGS LIMITED (MT) | 2004-08-26 | — | — | US | claimed |
| WO-2003099040-A1 | DIETARY SUPPLEMENTS FROM WINE VINASSES AND RELEVANT PRODUCTION PROCESS | ADVANCE HOLDINGS LIMITED (MT) | 2003-12-04 | — | — | WO | claimed |
| EP-0496349-B1 | Coating solution for preventing adhesion of polymer scale and method for its use | SHINETSU CHEMICAL CO (JP) | 1996-04-10 | — | — | EP | claimed |
| EP-0496349-A1 | Coating solution for preventing adhesion of polymer scale and method for its use | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1992-07-29 | — | — | EP | claimed |
| WO-2025070135-A1 | HEXAVALENT-CHROMIUM-REDUCING PHOTOCATALYST COMPOSITION AND METHOD FOR REDUCING HEXAVALENT CHROMIUM | ユシロ化学工業株式会社 | 2025-04-03 | — | — | WO | disclosed |
| US-20230415137-A1 | PHOTOCATALYST COMPOSITION, PHOTOCATALYST COMPOSITION SOLUTION, PHOTOCATALYST MEMBER, METHOD FOR USING PHOTOCATALYST COMPOSITION, AND SPACE DISINFECTION METHOD | YUSHIRO CHEMICAL INDUSTRY CO., LTD. (JP) | 2023-12-28 | — | — | US | disclosed |
| EP-0312222-B1 | TREATMENT OF DISEASES CAUSED BY VIRUSES | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo (JP) | 1992-08-05 | — | — | EP | disclosed |
| EP-0496349-A1 | Coating solution for preventing adhesion of polymer scale and method for its use | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1992-07-29 | — | — | EP | disclosed |
| EP-0312222-A1 | Treatment of diseases caused by viruses | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo (JP) | 1989-04-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230355769-A1 | COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS | CNR2, CNR1, UGT8 | F2 50/4885CD38 2308/4885DPP4 4789/4885 |
| US-20230338331-A1 | COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS | CNR2, CNR1, UGT8 | F2 50/4885CD38 2308/4885DPP4 4789/4885 |
| US-11523998-B2 | Anti-inflammatory formulations and uses thereof including a combination of palmitoylethanolamide and plant-based polyphenols | CPT2, FAAH2, LPCAT3 | F2 1965/4885CD38 1691/4885DPP4 783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.